Back to Search
JOEL NEUTEL, MD
MD
Legal Medicine
NPI: 1730163965IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
A50551(CA)
Legal MedicinePrimary
Legal Medicine
Code: 173000000X
A50551(CA)
CMS Specialties
PrimaryINTERNAL MEDICINE
Education
OTHER
Class of 1983
Research & Publications (20)
Adding nebivolol to ongoing antihypertensive therapy improves blood pressure and response rates in patients with uncontrolled stage I-II hypertension.
PMID 19404314·J Hum Hypertens·2010
2-rct
The use of a single-pill calcium channel blocker/statin combination in the management of hypertension and dyslipidemia: a randomized, placebo-controlled, multicenter study.
PMID 19125855·J Clin Hypertens (Greenwich)·2009
4-observational
Complementary mechanisms of angiotensin receptor blockers and calcium channel blockers in managing hypertension.
PMID 19332961·Postgrad Med·2009
6-review
A comparison of the efficacy and safety of irbesartan/HCTZ combination therapy with irbesartan and HCTZ monotherapy in the treatment of moderate hypertension.
PMID 17928878·J Hum Hypertens·2008
4-observational
Magnitude of the early morning blood pressure surge in untreated hypertensive patients: a pooled analysis.
PMID 18795972·Int J Clin Pract·2008
8-other
Prescribing patterns in hypertension: the emerging role of fixed-dose combinations for attaining BP goals in hypertensive patients.
PMID 18616863·Curr Med Res Opin·2008
6-review
Hypertension control: still not there-how to select the right add-on therapy to reach goal blood pressures.
PMID 17978597·J Clin Hypertens (Greenwich)·2007
8-other
Efficacy and safety of irbesartan/HCTZ combination therapy as initial treatment for rapid control of severe hypertension.
PMID 17170610·J Clin Hypertens (Greenwich)·2006
4-observational
The role of combination therapy in the management of hypertension.
PMID 16714336·Nephrol Dial Transplant·2006
6-review
Effects of a structured treatment algorithm on blood pressure goal rates in both stage 1 and stage 2 hypertension.
PMID 16397514·J Hum Hypertens·2006
4-observational
Comparison of a chronotherapeutically administered beta blocker vs. a traditionally administered beta blocker in patients with hypertension.
PMID 16015049·J Clin Hypertens (Greenwich)·2005
4-observational
Telmisartan/Hydrochlorothiazide in comparison with losartan/hydrochlorothiazide in managing patients with mild-to-moderate hypertension.
PMID 16335883·Hypertens Res·2005
4-observational
Efficacy of combination therapy for systolic blood pressure in patients with severe systolic hypertension: the Systolic Evaluation of Lotrel Efficacy and Comparative Therapies (SELECT) study.
PMID 16278521·J Clin Hypertens (Greenwich)·2005
4-observational
The efficacy and safety of low- and high-dose fixed combinations of irbesartan/hydrochlorothiazide in patients with uncontrolled systolic blood pressure on monotherapy: the INCLUSIVE trial.
PMID 16227760·J Clin Hypertens (Greenwich)·2005
2-rct
Comparison of monotherapy with irbesartan 150 mg or amlodipine 5 mg for treatment of mild-to-moderate hypertension.
PMID 16470487·J Renin Angiotensin Aldosterone Syst·2005
4-observational
Clinical experience with perindopril in elderly hypertensive patients: a subgroup analysis of a large community trial.
PMID 15449975·Am J Cardiovasc Drugs·2004
3-trial
Use of an olmesartan medoxomil-based treatment algorithm for hypertension control.
PMID 15073470·J Clin Hypertens (Greenwich)·2004
3-trial
Effect of antihypertensive monotherapy and combination therapy on arterial distensibility and left ventricular mass.
PMID 14700510·Am J Hypertens·2004
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 14351 MYFORD RD, SUITE B
TUSTIN, CA 92780 - Phone
- (714) 550-9990
Quick Facts
- NPI
- 1730163965
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 43
- Publications
- 20
Are you this provider?
Claim Your Profile